In both fundamental and applied sciences, cell-free protein expression is a crucial tool for molecular biologists. Researchers working on high-throughput functional proteomics and genomics are increasingly using cell-free protein expression because it offers several benefits over protein production in live cells. For enzyme engineering employing display technologies and the creation of protein arrays, such as nucleic acid programmable protein arrays, cell-free protein expression is important (NAPPA). A DNA template (which might be a plasmid or a polymerase chain reaction product) encoding the desired protein is needed for cell-free protein production, along with a solution containing all the enzymes and transcription and translation factors that are required.
This solution is a cell-free extract since the cell membrane has been removed, leaving just the organelle and cytosol. Expression of the target protein might begin when the genetic material and the cell-free extract are mixed together.
By 2030, the market for cell-free protein expression will surpass US$ 459.9 million.
The market for Cell-Free Protein Expression is anticipated to reach US$ 280.2 million in 2022 and grow at a 6.4% CAGR during the forecast period (2022-2030).
Key Leaders in the Cell-Free Protein Expression Industry:
1. Thermo Fisher Scientific Inc.
An American provider of scientific equipment, reagents, and consumables as well as software services is Thermo Fisher Scientific Inc. Thermo Fisher, headquartered in Waltham, Massachusetts, was created in 2006 by the union of Thermo Electron and Fisher Scientific. To address difficult analytical issues in research, diagnostics, and clinical laboratories, it is a provider of medical equipment, analytical instruments, reagents and consumables, software, and services. It provides answers for flow cytometry, synthetic biology, and cellular biology. The firm offers a variety of goods, including as technology for protein and molecular biology research, electron microscopy, mass spectrometry, and genetic sequencing. The business provides services to academic and research institutions, government agencies, pharmaceutical and biotech firms, clinical diagnostic laboratories, environmental, industrial quality, and process control sectors.Throughout the Americas, Asia-Pacific, and Europe, it offers its goods and services through its direct sales force, online sales, and third-party distributors. Waltham, Massachusetts, in the US, is home to Thermo Fisher's headquarters.
2. Takara Bio inc
Takara Bio USA, Inc., which was established in April 2002, offers kits, reagents, tools, and services to support study into topics relating to gene discovery, regulation, and function. Kusatsu, Shiga, Japan, is home to its headquarters. The business provides inducible systems, fluorescent proteins and reporters, cloning and competent cells, kits, reagents, and cell and molecular biology. The global operations of Clontech Labs. In order to imitate type 2 diabetes in a susceptible population, researchers created pancreatic beta cell-like cells from patient-specific tissue in 2023.
3. Promega Corporation
The 1978-founded Promega Corporation is a producer of enzymes and other products for biotechnology and molecular biology with headquarters in Madison, Wisconsin. The company's product line includes products for genomics, protein analysis and expression, cellular analysis, drug discovery, and genetic identity. The 2,000 products produced by Promega Corporation help scientists all around the world expand their understanding of life science research, notably in the fields of genomics, proteomics, and cellular analysis. The firm has between 1001 and 5000 workers and is based in the Madison, WI region.
4. New england biolabs
New England Biolabs, established in 1974, manufactures and distributes native and recombinant enzyme reagents for use in life science research, as well as offering goods and services to enable genome editing, synthetic biology, and next-generation sequencing. Research tools like REBASE, InBASE, and Polbase are also accessible without charge through NEB. With 350 workers and $43.0M in yearly revenue, Massachusetts-based New England Biolabs is a medium-sized healthcare organisation.